abstract Accumulation of neurofibrillary tangles (NFT), intracellular inclusions of fibrillar forms of tau, is a hallmark of Alzheimer's disease. NFT have been considered causative of neuronal death, however, recent evidence challenges this idea. Other species of tau, such as soluble misfolded, hyperphosphorylated, and mislocalized forms, are now being implicated as toxic. Here we review the data supporting soluble tau as toxic to neurons and synapses in the brain and the implications of these data for development of therapeutic strategies for Alzheimer's disease and other tauopathies.
introduction
More than 35 million individuals currently suffer from Alzheimer's disease (AD), a progressive neurodenegerative disorder with no known cure [1, 2] . The recent failure of several phase III clinical trials [3] and the knowledge that the number of AD patients is expected to double in the coming decades [4] , instigates the need for a closer look at the progress made in understanding AD and the gaps that still remain.
Since its original description in 1907, AD brain has been defined by the presence of extracellular β-amyloid (Aβ) containing plaques and cytoplasmic neurofibrillary tangles (NFT) consisting of abnormal microtubule associated protein tau [5, 6] . These proteinaceous aggregates are accompanied by synapse loss and neuronal cell death, which are thought to subserve the clinical syndrome of progressive cognitive impairment in AD [7] [8] [9] . The exact relationships and mechanisms between these four pathological hallmarks of AD have yet to be clearly defined, though it is largely believed that the initiating pathogen is the Aβ peptide [3, [10] [11] [12] [13] [14] . The strong support for the amyloid hypothesis has led the majority of the clinical trials to date to be rather Aβ-centric [15, 16] .
For some time following the discovery of the Aβ-linked genetics of AD, no tau mutations were identified that contributed to the disease, leading to the supposition that NFT are a downstream side-effect of Aβ toxicity and indicative of cell death [15] . Though it is still true that no mutations of tau have been linked to AD, a number of dementias known as tauopathies are known to result from alterations to the tau gene [17, 18] suggesting that changes in the tau protein are, in fact, sufficient to induce neurodegenerative processes. Furthermore, tau pathology correlates more closely than amyloid burden to neuronal loss, synaptic deficits and severity of disease and cognitive decline in AD [19] [20] [21] . These findings reinvigorated the investigation of tau as a pathologic entity in AD, ultimately leading to several clinical trials for tau-targeted therapies [2, 15] . In more recent years it has been shown that tau is a necessary mediator of Aβ toxicity [22] [23] [24] [25] [26] spurring the suggestion that AD may have several phases, first Aβ-dependent and then Aβ-independent but rather potentially tau dependent [27] . If this is the case, it is of course important to continue discovering Aβ mediated mechanisms of neurotoxicity and developing appropriately targeted therapeutics, but even more important is furthering our understanding of the mechanisms by which tau contributes to AD in order to develop complementary tautargeted therapies.
biology of tau
Tau is a microtubule-associated protein encoded by the MAPT gene on chromosome 17. Alternative splicing of 16 exons yields six isoforms of human tau that differ in number of amino acids (352-441), in number of N-terminal inserts (0-2N) and in number of microtubule binding domains (3R or 4R). In normal adult brain, the ratio of 3R:4R tau is ~1 and in AD this ratio is shifted toward excess 4R tau [1, 18] . Many of the tau mutations leading to dementia alter the splicing of the tau protein also increasing the presence of 4R tau [18, 28] .
The number of microtubule binding domains in tau determines the affinity for microtubules (3R < 4R), thereby mediating the primary function of tau in stabilizing axonal microtubules and enabling their polymerization and assembly [4, 28] . As microtubules serve as the highways for trafficking of molecules within the axon, this places tau as a central player in neuronal transport and therefore function [29] . Also contributing to the microtubule stabilizing capacity of tau are post-translational modifications, particularly phosphorylation, which when elevated, decreases affinity of tau for microtubules and causes it to detach [4, 18] . Tau has over 80 phosphorylation sites, some of which are considered physiological while others are 'de-novo' phosphorylated in disease states [30] . Two families of protein kinases contribute to tau phosphorylation, those that are proline directed and tend to phosphorylate serine and threonine motifs outside the microtubule binding domain and those that are KXGS-motif and non-proline directed and tend to phosphorylate within the repeat domain [14, 31] . Proline directed kinases that phosphorylate tau include GSK3β, MAPK (mitogen activated protein kinase), JNK (c-Jun N terminal kinase) and cyclin-dependent kinase 5 (Cdk5) and have been the target of some of the preliminary tau-targeted therapies [14] [15] [16] 18] . Kinases targeting KXGS and other non-proline motives include microtubule affinity regulating kinase (MARK), P70S6K, BRSK, PKA and CaMKII [14, 28] , with MARK recently being implicated as a critical mediator of both Aβ and tau toxicity [26] . In physiological conditions the activities of the kinases are dynamically counterbalanced by the primary tau directed protein phosphatases PP2A and PP1 [18, 28] .
Pathological forms of tau
In disease states such as AD, it is thought that the balance of kinase and phosphatase activity is shifted, creating a hyperphosphorylated species of tau [1, 28] . This increases the fraction of tau that is no longer attached to microtubules, allowing for monomeric hyperphosphorylated tau to bind one another to produce oligomers [32] [33] [34] . These oligomers are missorted from the axonal to somatodendritic compartment [35] [36] [37] , where they undergo further hyperphosphorylation and conformational change and take on a beta-sheet structure that is considered insoluble. Fusion of these oligomeric species contributes to the formation of paired helical filaments (PHF), the primary constituent of NFT [28, [38] [39] [40] .
As is the case with other proteins involved in neurodegenerative diseases, the question of which variety of tau is most toxic and whether that toxicity represents a gain or loss of function continues to be debated [11, 37, 41] . We favor the third model of toxicity as will be discussed.
Historically, NFT were considered indicators of cell death, particularly given that their progression and number correlate well with severity of cognitive decline in AD, while Aβ plaque deposition does not [19] [20] [21] 42, 43] .
NFT bearing neurons of human AD brain have been shown to have abnormal quantity or distribution of molecules necessary for proper function such as synaptic proteins [7, 37] , and calcium binding proteins [44] [45] [46] [47] and NFT have been suggested to interfere with basic cell function as they serve as a physical disruption or space occupying lesion [28, 29] . In a mouse model of tauopathy, expression of an aggregation prone tau molecule causes morphological and functional deficits while expression of a similar but anti-aggregation tau molecule has no such negative consequences [39, 48, 49] . NFT toxicity is also supported by cell culture models in which tau aggregation leads to activation of caspase cascades and cell death [18] .
Significant data, however, have also accumulated for the contrarian view that NFT may be silent bystanders, thereby implicating soluble tau species or other pathological processes, but in an indirect manner. Many cognitively normal individuals accumulate NFT, with pathological changes in tau occurring as early as the age of 6 in brainstem nuclei [43] . AD is often not diagnosed until NFT have spread throughout much of the brain [42, 50] . Frontotemporal dementias known to be caused by mutations in tau in humans, and a number of animal models demonstrate severe neuronal cell loss and dysfunction in the absence of overt or coinciding NFT pathology [18, 21, 28, 38, [51] [52] [53] . Several studies in a mouse model that reversibly expresses a human mutant form of tau (rTg4510) show dissociation between neuronal loss and NFT accumulation, particularly after suppressing the tau transgene, at which point neuronal loss stops though NFT persist and continue to accumulate [54, 55] . Additional studies in these animals have shown that the presence of a tangle does not alter spine density, electrophysiological function [2, 56] or ability to respond to physiologically relevant stimuli [57] in comparison to nontangle bearing neighboring neurons. In fact, NFT appearance in these animals is preceded by caspase activation and these neurons endure longer than anticipated following activation of these traditional cell death signaling cascades [58, 59] . Emerging from these findings is a theory that NFT, rather than representing silent markers of cell death, may serve as a protective mechanism of sequestering toxic soluble tau species [18, 37] .
Evidence for the toxicity of soluble tau species has been growing in recent years despite the fact that it remains an ill-defined species. It is now thought that phosphorylation, localization and conformational changes to tau are sufficient for occurrence of toxic effects and represent a pre-tangle stage.
These early alterations have been proposed as the beginning of the pathological process of AD [35, 42, 43, 50, 60] . A large number of invitro studies have shown that over-expression of tau or alterations in its phosphorylation state, localization or conformation induce changes in calcium homeostasis, loss of dendritic spines, impaired trafficking of organelles, particularly mitochondria, and cell death [14, 18, 28, 36, 37, 40, [60] [61] [62] [63] [64] [65] [66] [67] .
Studies in mouse models support these findings, demonstrating correlations between soluble tau species and neuronal or synaptic dysfunction [37, 49, 52, [68] [69] [70] . [44, 46, 75, 80, 82, 114, 115] . Synapse loss is the leading correlate to cognitive decline in AD [7, 8, 116] , correlating more closely even than NFT [19] [20] [21] , and yet the mechanism of synaptic degeneration in AD and other tauopathies is not clearly understood and rather controversial. Reports of synapse loss in tau models vary dramatically with some studies suggesting negligible or no spine loss [38, 60, 69, 88] , others demonstrating significant synaptic deterioration [10, 14, 39, 49, 56, 67] and The predominant means by which it is thought that pathological changes in tau may disrupt axonal transport, is via destabilization of microtubules, leading to their disassembly [11, 29] . Future studies are needed to confirm these hypotheses about the toxicity of soluble vs fibrillar tau and the molecular mechanisms of toxicity. In vivo multiphoton imaging provides a powerful tool for addressing these issues of causality and temporal progression of disease.
We have observed cell death over the course of days in YFPxrTg4510 mice occurring at a rate of approximately 2% per week ( Figure 2) using cranial window implantation and multiphoton imaging of YFP as described previously [132] . This is similar to the 4.6% loss of yfp cells per month reported in living 3XTg mice that express mutant amyloid precursor protein, mutant tau, and mutant presenilin that the neuron has reached a threshold for soluble tau, initiating a compensatory mechanism that ultimately is unable to save the cell. These data also suggest that Figure 2 . Cell death in tauopathy model mice. In vivo multiphoton imaging of neurons in mice expressing yellow fluorescent protein and P301L mutant tau (YFPxrTg4510 line) in pyramidal neurons undergo cell death (asterisk indicates a cell that died between one day and the next). Postmortem staining (bottom) confirms that YFP expressing neurons also express human tau in this model. Neuronal death is halted by transgene suppression in rTg4510 mice without removing existing tangles [54] , and caspase activation, which occurs in neurons before NFT form, is turned off after tangle formation [113] 
